SGIOY.US Shionogi & Co Ltd ADR

Healthcare Pharmaceuticals USA Stocks
9.88 USD
Close of Nov 17, 2026
8.11 11.32
Market cap
USD 16.8B
P/E
11.0x
P/B
1.54x
ROE
13.8%
Dividend yield
1.17%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is SGIOY.US undervalued?

Graham number
Price9.88
Graham value11.41
Discount13.4%

SGIOY.US trades 13.4% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shionogi & Co Ltd ADR fundamental analysis

No fundamental analysis for Shionogi & Co Ltd ADR yet.

Shionogi & Co Ltd ADR stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shionogi & Co Ltd ADR

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and busines…

Full company profile